Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 22, 2019

DrugPatentWatch Database Preview

Eculizumab - Biologic Drug Details

« Back to Dashboard

Summary for eculizumab

Tradenames:	1
Patents:	60
Applicants:	1
BLAs:	1
Suppliers: see list	1
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for eculizumab

Pharmacology for eculizumab

Mechanism of Action	Complement Inhibitors

US Patents for eculizumab

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Alexion Pharm	SOLIRIS	eculizumab	INJECTABLE; IV (INFUSION)	125166	001	2007-03-16	➤ Sign Up	CureVac AG (Tubingen, DE)	➤ Sign Up	RX	Orphan	search
Alexion Pharm	SOLIRIS	eculizumab	INJECTABLE; IV (INFUSION)	125166	001	2007-03-16	➤ Sign Up	Alexion Pharmaceuticals, Inc. (Cheshire, CT)	➤ Sign Up	RX	Orphan	company
Alexion Pharm	SOLIRIS	eculizumab	INJECTABLE; IV (INFUSION)	125166	001	2007-03-16	➤ Sign Up	Janssen Pharmaceutica NV (Beerse, BE)	➤ Sign Up	RX	Orphan	search
Alexion Pharm	SOLIRIS	eculizumab	INJECTABLE; IV (INFUSION)	125166	001	2007-03-16	➤ Sign Up	Aegis Therapeutics LLC (San Diego, CA)	➤ Sign Up	RX	Orphan	search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for eculizumab

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
Japan	2016537380	➤ Sign Up
Russian Federation	2600876	➤ Sign Up
Serbia	58343	➤ Sign Up
Lithuania	3071219	➤ Sign Up
Country	Patent Number	Estimated Expiration

Supplementary Protection Certificates for eculizumab

Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C/GB10/015	United Kingdom	➤ Sign Up	PRODUCT NAME: ECULIZUMAB; REGISTERED: UK EU/1/07/393/001 20070620
00433	Netherlands	➤ Sign Up	PRODUCT NAME: ECULIZUMAB; REGISTRATION NO/DATE: EU/1/07/393/001 20070620
12/2010	Austria	➤ Sign Up	PRODUCT NAME: ECULIZUMAB
C002/2010	Ireland	➤ Sign Up	SPC002/2010: 20100902, EXPIRES: 20200430
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.